BGM
CABA icon

Burkehill Global Management’s Cabaletta Bio CABA Stock Holding History

Burkehill Global Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Hold
700,000
– – 0.09% 127
2025
Q4 		$1.53M Hold
700,000
– – 0.1% 132
2025
Q3 		$1.64M Sell
700,000
-1,200,000
-63% -$2.06M 0.09% 126
2025
Q2 		$2.89M Buy
+1,900,000
New +$2.96M 0.21% 76

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Burkehill Global Management's CABA Position: Q1 2026 in Review

Burkehill Global Management held its Cabaletta Bio (CABA) position steady in Q1 2026 at 700,000 shares worth $1.88M. The position accounts for 0.09% of the portfolio, ranked #127.

Burkehill Global Management first reported a position in CABA in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.89M in Q2 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Burkehill Global Management held 700,000 shares of Cabaletta Bio worth $1.88M as of Q1 2026.
  • Burkehill Global Management left its Cabaletta Bio share count unchanged in Q1 2026.
  • Cabaletta Bio made up 0.09% of Burkehill Global Management's portfolio in Q1 2026, its #127 holding.
  • Burkehill Global Management first reported a position in Cabaletta Bio in Q2 2025 and has held it in 4 quarters since.
  • Burkehill Global Management's Cabaletta Bio position peaked at $2.89M in Q2 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.